NAYA Biosciences, Inc (NASDAQ:NAYA) — Market Cap & Net Worth
Market Cap & Net Worth: NAYA Biosciences, Inc (NAYA)
NAYA Biosciences, Inc (NASDAQ:NAYA) has a market capitalization of $2.48 Million ($2.48 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29733 globally and #5986 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NAYA Biosciences, Inc's stock price $2.20 by its total outstanding shares 4476220 (4.48 Million). See NAYA capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
NAYA Biosciences, Inc Market Cap History: 2015 to 2025
NAYA Biosciences, Inc's market capitalization history from 2015 to 2025. Data shows growth from $3.13 Million to $9.85 Million (17.70% CAGR).
Index Memberships
NAYA Biosciences, Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #875 of 976 |
Weight: NAYA Biosciences, Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NAYA Biosciences, Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NAYA Biosciences, Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
NAYA Biosciences, Inc's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.13 Million | $11.69K | -$4.96 Million | 268.06x | N/A |
| 2016 | $1.57 Million | $50.90K | -$2.12 Million | 30.78x | N/A |
| 2017 | $693.81K | $282.14K | -$702.16K | 2.46x | N/A |
| 2018 | $1.88 Million | $494.38K | -$3.08 Million | 3.80x | N/A |
| 2019 | $967.76K | $1.48 Million | -$2.17 Million | 0.65x | N/A |
| 2020 | $269.47 Million | $1.04 Million | -$8.35 Million | 259.78x | N/A |
| 2021 | $298.12 Million | $4.16 Million | -$6.65 Million | 71.66x | N/A |
| 2022 | $37.96 Million | $822.20K | -$10.89 Million | 46.17x | N/A |
| 2023 | $6.04 Million | $3.02 Million | -$8.03 Million | 2.00x | N/A |
| 2024 | $3.63 Million | $6.53 Million | -$9.10 Million | 0.56x | N/A |
Competitor Companies of NAYA by Market Capitalization
Companies near NAYA Biosciences, Inc in the global market cap rankings as of August 3, 2026.
Key companies related to NAYA Biosciences, Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
NAYA Biosciences, Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, NAYA Biosciences, Inc's market cap moved from $3.13 Million to $ 9.85 Million, with a yearly change of 17.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $9.85 Million | +171.60% |
| 2024 | $3.63 Million | -40.00% |
| 2023 | $6.04 Million | -84.08% |
| 2022 | $37.96 Million | -87.27% |
| 2021 | $298.12 Million | +10.63% |
| 2020 | $269.47 Million | +27744.59% |
| 2019 | $967.76K | -48.52% |
| 2018 | $1.88 Million | +170.97% |
| 2017 | $693.81K | -55.71% |
| 2016 | $1.57 Million | -50.00% |
| 2015 | $3.13 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of NAYA Biosciences, Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.48 Million USD |
| MoneyControl | $2.48 Million USD |
| MarketWatch | $2.48 Million USD |
| marketcap.company | $2.48 Million USD |
| Reuters | $2.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NAYA Biosciences, Inc
INVO Fertility, Inc., a life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases. The company operates in two divisions, NAYA Women's Health and NAYA Therapeutics. Its lead product includes NY-303, a GPC3-targeted FLEX-NK bispecific antibody that is in Phase I/II clinical trials for hepatocellular carcinoma, as well as soli… Read more